Cargando…
Adipose stromal vascular fraction attenuates T(H)1 cell-mediated pathology in a model of multiple sclerosis
BACKGROUND: The therapeutic efficacy of adipose-derived stem cells (ASCs) has been investigated for numerous clinical indications, including autoimmune and neurodegenerative diseases. Less is known using the crude adipose product called stromal vascular fraction (SVF) as therapy, although our previo...
Autores principales: | Bowles, Annie C., Wise, Rachel M., Gerstein, Brittany Y., Thomas, Robert C., Ogelman, Roberto, Manayan, Regan C., Bunnell, Bruce A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850918/ https://www.ncbi.nlm.nih.gov/pubmed/29534751 http://dx.doi.org/10.1186/s12974-018-1099-3 |
Ejemplares similares
-
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis
por: Riordan, Neil H, et al.
Publicado: (2009) -
Characterization of a Murine Pressure Ulcer Model to Assess Efficacy of Adipose-derived Stromal Cells
por: Strong, Amy L., et al.
Publicado: (2015) -
Mechanical Fractionation of Adipose Tissue—A Scoping Review of Procedures to Obtain Stromal Vascular Fraction
por: Schipper, Jan Aart M., et al.
Publicado: (2023) -
Therapeutic applications of adipose-derived stromal vascular fractions in osteoarthritis
por: Tang, Qi, et al.
Publicado: (2022) -
Comparison of human adipose stromal vascular fraction and adipose-derived mesenchymal stem cells for the attenuation of acute renal ischemia/reperfusion injury
por: Zhou, Liuhua, et al.
Publicado: (2017)